Fingerprint
Dive into the research topics of 'Pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically